Directorate Change

RNS Number : 3073U
Glanbia PLC
29 July 2022
 

 

29 July 2022, Glanbia plc ("Glanbia", the "Company" or "plc"), the global nutrition group, announces the following changes to its Board of Directors and its Committees .

Director changes

Ms. Ilona Haaijer and Ms. Kimberly Underhill will join the Board as Independent Non-Executive Directors effective 1 August 2022.

Ilona Haaijer

Ms. Haaijer, a Dutch citizen, brings extensive and significant leadership experience of strategic development, change management, mergers and acquisitions and leading complex, global businesses in the food ingredients and consumer sectors.

Ms Haaijer is a former President and CEO of DSM Food Specialties, President of DSM Personal Care, CEO of Bugaboo International, CEO of Philips AVENT, Vice President Corporate Strategy of Royal Philips Electronics, and Consultant at The Boston Consulting Group. From her career, Ms Haaijer brings significant international experience of food ingredient and consumer oriented businesses.

Ms. Haaijer is currently Non-Executive Director of Corbion N.V., an Amsterdam based Euronext listed food and bio-technology company. Ms Haaijer is former Non-Executive Director of RPC Group plc and Royal Boskalis Westminster N.V.

Ms Haaijer graduated from the University of Groningen, Netherlands with an MA in Business Economics.

Kimberly Underhill

Ms. Underhill, a US citizen, brings extensive and significant leadership experience in US and international consumer products businesses, with particular strength in product development, marketing, portfolio management, brand-building, strategic planning and international business development.

Ms. Underhill is a former Group President, Consumer Business North America, Kimberly-Clark. Ms. Underhill held a number of key positions during her 33 year career with Kimberly-Clark within research and engineering, operations and marketing, leading several of Kimberly-Clark's most strategic businesses including as Global President, Kimberly-Clark Professional and as President, Consumer Europe.

Ms. Underhill is currently a Non-Executive Director of Foot Locker, Inc. the global sportswear and footwear retailer listed on the New York Stock Exchange. She is on the Board of Trustees of Theda Care Regional Medical Center, is a Director of The Menasha Corporation (a privately held company that is a packaging manufacturer and provider of supply chain solutions)  and is Co-Chair of Fox Cities United Way Campaign.

Previously she chaired the Network of Executive Women (women's leadership organization serving retail and consumer goods industries) and was a director of the Food Marketing Institute,

Ms. Underhill graduated from Milwaukee School of Engineering, USA with a MSc Engineering Management, and Purdue University, USA with a BSc Chemical Engineering.

 

 

Compliance with Listing Rules

Ms. Haaijer and Ms. Underhill have notified Glanbia plc that, save as disclosed herein, they do not have any details to be disclosed as required under Paragraph 6.1.66, Chapter 6 of the Euronext Dublin Listing Rules and Paragraph 9.6.13, Chapter 9 of the UK Listing Rules.

Committee changes

Following the above appointments, the Company's Committees will be reconstituted as follows:

Audit

Nomination and Governance

Remuneration

Environmental, Social and Governance

Corporate Development

Paul Duffy
(Chair)

Donard Gaynor (Chair)

Jane Lodge
(Chair)

Donard Gaynor
(Chair)

Donard Gaynor
(Chair)

Ilona Haaijer

Roisin Brennan

Roisin Brennan

Ilona Haaijer

Roisin Brennan

Jane Lodge

Dan O'Connor

Paul Duffy

John G Murphy

Paul Duffy

Kimberly Underhill


Donard Gaynor

Siobhán Talbot

Mark Garvey



Kimberly Underhill


Ilona Haaijer









Jane Lodge





Dan O'Connor





Siobhán Talbot





Kimberly Underhill

 

For further information contact

Glanbia plc +353 56 777 2200

Liam Hennigan, Group Secretary & Head of Investor Relations: +353 86 046 8375

Martha Kavanagh, Head of Corporate Communications: +353 87 646 200

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAEADXNAEAAEFA
Investor Meets Company
UK 100